| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Journal of Applied Physiology, Vol 71, Issue 6 2218-2223, Copyright © 1991 by American Physiological Society
ARTICLES |
S. P. Janssens, B. T. Thompson, C. R. Spence and C. A. Hales
Massachusetts General Hospital, Department of Medicine (Pulmonary/Critical Care Unit), Boston.
Chronic hypoxia increases pulmonary arterial pressure (PAP) as a result of vasoconstriction, polycythemia, and vascular remodeling with medial thickening. To determine whether preventing the polycythemia with repeated bleeding would diminish the pulmonary hypertension and remodeling, we compared hemodynamic and histological profiles in hypoxic bled (HB, n = 6) and hypoxic polycythemic guinea pigs (H, n = 6). After 10 days in hypoxia (10% O2), PAP was increased from 10 +/- 1 (SE) mmHg in room air controls (RA, n = 5) to 20 +/- 1 mmHg in H (P less than 0.05) but was lower in HB (15 +/- 1 mmHg, P less than 0.05 vs. H). Cardiac output and pulmonary artery vasoreactivity did not differ among groups. Total pulmonary vascular resistance increased from 0.072 +/- 0.011 mmHg.ml-1.min in RA to 0.131 mmHg.ml-1.min in H but was significantly lower in HB (0.109 +/- 0.006 mmHg.ml-1.min). Hematocrit increased with hypoxia (57 +/- 3% in H vs. 42 +/- 1% in RA, P less than 0.05), and bleeding prevented the increase (46 +/- 4% in HB, P less than 0.05 vs. H only). The proportion of thick-walled peripheral pulmonary vessels (53.2 +/- 2.9% in HB and 50.6 +/- 4.8% in H vs. 31.6 +/- 2.6% in RA, P less than 0.05) and the percent medial thickness of pulmonary arteries adjacent to alveolar ducts (7.2 +/- 0.6% in HB and 7.0 +/- 0.4% in H vs. 5.2 +/- 0.4% in RA, P less than 0.05) increased to a similar degree in both hypoxic groups. A similar tendency was present in larger bronchiolar vessels.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  E. Al-Ansari, H.-k. Du, L. Yu, C. D. Ochoa, H. G. Garg, D. A. Quinn, and C. A. Hales Low-Molecular-Weight Heparin Inhibits Hypoxic Pulmonary Hypertension and Vascular Remodeling in Guinea Pigs Chest, December 1, 2007; 132(6): 1898 - 1905. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pokreisz, G. Marsboom, and S. Janssens Pressure overload-induced right ventricular dysfunction and remodelling in experimental pulmonary hypertension: the right heart revisited Eur. Heart J. Suppl., December 1, 2007; 9(suppl_H): H75 - H84. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Faber, C. L. Szymeczek, S. Cotecchia, S. A. Thomas, A. Tanoue, G. Tsujimoto, and H. Zhang {alpha}1-Adrenoceptor-dependent vascular hypertrophy and remodeling in murine hypoxic pulmonary hypertension Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2316 - H2323. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Favret, K. K. Henderson, J. Allen, J.-P. Richalet, and N. C. Gonzalez Exercise training improves lung gas exchange and attenuates acute hypoxic pulmonary hypertension but does not prevent pulmonary hypertension of prolonged hypoxia J Appl Physiol, January 1, 2006; 100(1): 20 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Girgis, D. Li, X. Zhan, J. G. N. Garcia, R. M. Tuder, P. M. Hassoun, and R. A. Johns Attenuation of chronic hypoxic pulmonary hypertension by simvastatin Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H938 - H945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. F. Wagner, D. M. Katschinski, J. Hasegawa, D. Schumacher, B. Meller, U. Gembruch, U. Schramm, W. Jelkmann, M. Gassmann, and J. Fandrey Chronic inborn erythrocytosis leads to cardiac dysfunction and premature death in mice overexpressing erythropoietin Blood, January 15, 2001; 97(2): 536 - 542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. KANAZAWA, T. OKAMOTO, K. HIRATA, and J. YOSHIKAWA Deletion Polymorphisms in the Angiotensin Converting Enzyme Gene Are Associated with Pulmonary Hypertension Evoked by Exercise Challenge in Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1235 - 1238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Y. Yu, M. G. Frid, L. A. Shimoda, C. M. Wiener, K. Stenmark, and G. L. Semenza Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung Am J Physiol Lung Cell Mol Physiol, October 1, 1998; 275(4): L818 - L826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. van SUYLEN, J. F. M. SMITS, and M. J. A. P. DAEMEN Pulmonary Artery Remodeling Differs in Hypoxia- and Monocrotaline-induced Pulmonary Hypertension Am. J. Respir. Crit. Care Med., May 1, 1997; 157(5): 1423 - 1428. [Abstract] [Full Text]
|
|
|
|
|
|
C. DEFOUILLOY, E. TEIGER, S. SEDIAME, P. ANDRIVET, F. ROUDOT-THORAVAL, C. CHOUAID, B. HOUSSET, and S. ADNOT Polycythemia Impairs Vasodilator Response to Acetylcholine in Patients with Chronic Hypoxemic Lung Disease Am. J. Respir. Crit. Care Med., May 1, 1997; 157(5): 1452 - 1460. [Abstract] [Full Text]
|
|
|
|
 |
|
 Z. Nong, J.-M. Stassen, L. Moons, D. Collen, and S. Janssens Inhibition of Tissue Angiotensin-Converting Enzyme With Quinapril Reduces Hypoxic Pulmonary Hypertension and Pulmonary Vascular Remodeling Circulation, October 15, 1996; 94(8): 1941 - 1947. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
